Published in Vaccine Weekly, March 21st, 2001
Researchers working in France explored the idea that asthma is an over-response of T-helper lymphocyte phenotype 2 (Th-2) in children who have not been previously exposed to Th-l-inducing infections.
"We tested the hypothesis that BCG vaccination in Th-2-susceptible newborn BP2 mice blocks allergic inflammation and bronchial hyper-reactivity (BHR)," explained M.A. Nahori and colleagues.
The researchers inoculated...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2001-03-21)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.